Hydrogen Bonds Fight HIV Mutations

  • Author: Melania Tesio
  • Published: 05 February 2013
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
  • Source / Publisher: Nature Chemistry/Nature Publishing Group
thumbnail image: Hydrogen Bonds Fight HIV Mutations

The drug rilpivirine potently and effectively inhibits the replication of the human immunodeficiency virus (HIV), a pathogen which causes a progressive failure of the immune system known as acquired immunodeficiency syndrome (AIDS). This drug is effective against mutant viruses as it binds and inhibits an essential enzyme for the viral replication, the reverse transcriptase, even when this protein undergoes structural mutations to cause drug-resistance.

Daniel Kuroda, University of Pennsylvania, USA, and colleagues identified the exact structural basis of this phenomenon. The scientists demonstrated that hydrogen bond interactions occurring between a water molecule and the cinnamonitrile group of the drug anchor rilpirivine to HIV reverse transcriptase. As a consequence, structural mutations occurring in the enzyme do not provoke the expulsion of the drug from the binding pocket.
Thus, interactions between water and cinnamonitrile group need to be considered when designing anti HIV drugs.


Article Views: 2000

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH